HEADER HYDROLASE/HYDROLASE INHIBITOR 01-AUG-12 4GE5 TITLE CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) TITLE 2 COMPLEX WITH COMPOUND 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 9; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TYROSINE-PROTEIN PHOSPHATASE DOMAIN (UNP RESIDUES 277-582); COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE MEG2, PTPASE MEG2; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: PHAGE-RESISTANT DERIVATIVE OF BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-CH KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.-Y.ZHANG,S.LIU,S.ZHANG REVDAT 3 13-SEP-23 4GE5 1 REMARK SEQADV REVDAT 2 14-NOV-12 4GE5 1 JRNL REVDAT 1 31-OCT-12 4GE5 0 JRNL AUTH S.ZHANG,S.LIU,R.TAO,D.WEI,L.CHEN,W.SHEN,Z.H.YU,L.WANG, JRNL AUTH 2 D.R.JONES,X.C.DONG,Z.Y.ZHANG JRNL TITL A HIGHLY SELECTIVE AND POTENT PTP-MEG2 INHIBITOR WITH JRNL TITL 2 THERAPEUTIC POTENTIAL FOR TYPE 2 DIABETES. JRNL REF J.AM.CHEM.SOC. V. 134 18116 2012 JRNL REFN ISSN 0002-7863 JRNL PMID 23075115 JRNL DOI 10.1021/JA308212Y REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1218.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.3 REMARK 3 NUMBER OF REFLECTIONS : 34622 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1356 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4828 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 356 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.76000 REMARK 3 B22 (A**2) : -4.82500 REMARK 3 B33 (A**2) : 10.58600 REMARK 3 B12 (A**2) : 4.71000 REMARK 3 B13 (A**2) : 3.08000 REMARK 3 B23 (A**2) : -3.85200 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 52.96 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 3 : A89_PAR.TXT REMARK 3 PARAMETER FILE 4 : CNS_TOPPAR:WATER.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GE5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074069. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52574 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 4GE2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.2 M POTASSIUM REMARK 280 THIOCYANATE, 10% ETHYLENE GLYCOL, 0.1 M BIS-TRIS PROPANE, PH 6.7, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 276 REMARK 465 GLY A 499 REMARK 465 ALA A 500 REMARK 465 ARG A 501 REMARK 465 SER A 502 REMARK 465 LYS A 503 REMARK 465 GLY A 504 REMARK 465 GLN A 505 REMARK 465 CYS A 506 REMARK 465 PRO A 507 REMARK 465 HIS A 584 REMARK 465 HIS A 585 REMARK 465 HIS A 586 REMARK 465 HIS A 587 REMARK 465 HIS A 588 REMARK 465 HIS A 589 REMARK 465 MET B 276 REMARK 465 GLY B 499 REMARK 465 ALA B 500 REMARK 465 ARG B 501 REMARK 465 SER B 502 REMARK 465 LYS B 503 REMARK 465 GLY B 504 REMARK 465 GLN B 505 REMARK 465 CYS B 506 REMARK 465 PRO B 507 REMARK 465 HIS B 585 REMARK 465 HIS B 586 REMARK 465 HIS B 587 REMARK 465 HIS B 588 REMARK 465 HIS B 589 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 289 CG CD OE1 NE2 REMARK 470 GLU A 508 CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 384 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 299 -179.65 71.80 REMARK 500 LYS A 348 -162.91 -74.78 REMARK 500 SER A 350 -159.17 -54.94 REMARK 500 HIS A 352 31.70 -150.05 REMARK 500 THR A 353 79.48 44.54 REMARK 500 ASP A 421 -22.11 83.32 REMARK 500 ASN A 542 101.70 -160.05 REMARK 500 ILE A 558 98.58 79.78 REMARK 500 GLN B 299 -176.00 65.67 REMARK 500 ASP B 421 -40.19 89.09 REMARK 500 SER B 467 49.01 -94.71 REMARK 500 SER B 496 20.45 -69.42 REMARK 500 CYS B 515 -130.41 -134.96 REMARK 500 ILE B 558 97.93 77.14 REMARK 500 VAL B 581 -160.28 -115.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-(4-BROMO-3-METHYLBENZOYL)-4-[DIFLUORO(PHOSPHONO) REMARK 630 METHYL]-L-PHENYLALANYL-N~5~-(3-IODOBENZOYL)-L-ORNITHINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 A89 A 601 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 0GF FTY 0G5 NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A89 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GE2 RELATED DB: PDB REMARK 900 RELATED ID: 4GE6 RELATED DB: PDB DBREF 4GE5 A 277 582 UNP P43378 PTN9_HUMAN 277 582 DBREF 4GE5 B 277 582 UNP P43378 PTN9_HUMAN 277 582 SEQADV 4GE5 MET A 276 UNP P43378 INITIATING METHIONINE SEQADV 4GE5 ALA A 583 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS A 584 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS A 585 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS A 586 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS A 587 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS A 588 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS A 589 UNP P43378 EXPRESSION TAG SEQADV 4GE5 MET B 276 UNP P43378 INITIATING METHIONINE SEQADV 4GE5 ALA B 583 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS B 584 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS B 585 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS B 586 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS B 587 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS B 588 UNP P43378 EXPRESSION TAG SEQADV 4GE5 HIS B 589 UNP P43378 EXPRESSION TAG SEQRES 1 A 314 MET SER VAL HIS VAL PRO GLY PRO HIS ALA MET THR ILE SEQRES 2 A 314 GLN GLU LEU VAL ASP TYR VAL ASN ALA ARG GLN LYS GLN SEQRES 3 A 314 GLY ILE TYR GLU GLU TYR GLU ASP ILE ARG ARG GLU ASN SEQRES 4 A 314 PRO VAL GLY THR PHE HIS CYS SER MET SER PRO GLY ASN SEQRES 5 A 314 LEU GLU LYS ASN ARG TYR GLY ASP VAL PRO CYS LEU ASP SEQRES 6 A 314 GLN THR ARG VAL LYS LEU THR LYS ARG SER GLY HIS THR SEQRES 7 A 314 GLN THR ASP TYR ILE ASN ALA SER PHE MET ASP GLY TYR SEQRES 8 A 314 LYS GLN LYS ASN ALA TYR ILE GLY THR GLN GLY PRO LEU SEQRES 9 A 314 GLU ASN THR TYR ARG ASP PHE TRP LEU MET VAL TRP GLU SEQRES 10 A 314 GLN LYS VAL LEU VAL ILE VAL MET THR THR ARG PHE GLU SEQRES 11 A 314 GLU GLY GLY ARG ARG LYS CYS GLY GLN TYR TRP PRO LEU SEQRES 12 A 314 GLU LYS ASP SER ARG ILE ARG PHE GLY PHE LEU THR VAL SEQRES 13 A 314 THR ASN LEU GLY VAL GLU ASN MET ASN HIS TYR LYS LYS SEQRES 14 A 314 THR THR LEU GLU ILE HIS ASN THR GLU GLU ARG GLN LYS SEQRES 15 A 314 ARG GLN VAL THR HIS PHE GLN PHE LEU SER TRP PRO ASP SEQRES 16 A 314 TYR GLY VAL PRO SER SER ALA ALA SER LEU ILE ASP PHE SEQRES 17 A 314 LEU ARG VAL VAL ARG ASN GLN GLN SER LEU ALA VAL SER SEQRES 18 A 314 ASN MET GLY ALA ARG SER LYS GLY GLN CYS PRO GLU PRO SEQRES 19 A 314 PRO ILE VAL VAL HIS CYS SER ALA GLY ILE GLY ARG THR SEQRES 20 A 314 GLY THR PHE CYS SER LEU ASP ILE CYS LEU ALA GLN LEU SEQRES 21 A 314 GLU GLU LEU GLY THR LEU ASN VAL PHE GLN THR VAL SER SEQRES 22 A 314 ARG MET ARG THR GLN ARG ALA PHE SER ILE GLN THR PRO SEQRES 23 A 314 GLU GLN TYR TYR PHE CYS TYR LYS ALA ILE LEU GLU PHE SEQRES 24 A 314 ALA GLU LYS GLU GLY MET VAL SER ALA HIS HIS HIS HIS SEQRES 25 A 314 HIS HIS SEQRES 1 B 314 MET SER VAL HIS VAL PRO GLY PRO HIS ALA MET THR ILE SEQRES 2 B 314 GLN GLU LEU VAL ASP TYR VAL ASN ALA ARG GLN LYS GLN SEQRES 3 B 314 GLY ILE TYR GLU GLU TYR GLU ASP ILE ARG ARG GLU ASN SEQRES 4 B 314 PRO VAL GLY THR PHE HIS CYS SER MET SER PRO GLY ASN SEQRES 5 B 314 LEU GLU LYS ASN ARG TYR GLY ASP VAL PRO CYS LEU ASP SEQRES 6 B 314 GLN THR ARG VAL LYS LEU THR LYS ARG SER GLY HIS THR SEQRES 7 B 314 GLN THR ASP TYR ILE ASN ALA SER PHE MET ASP GLY TYR SEQRES 8 B 314 LYS GLN LYS ASN ALA TYR ILE GLY THR GLN GLY PRO LEU SEQRES 9 B 314 GLU ASN THR TYR ARG ASP PHE TRP LEU MET VAL TRP GLU SEQRES 10 B 314 GLN LYS VAL LEU VAL ILE VAL MET THR THR ARG PHE GLU SEQRES 11 B 314 GLU GLY GLY ARG ARG LYS CYS GLY GLN TYR TRP PRO LEU SEQRES 12 B 314 GLU LYS ASP SER ARG ILE ARG PHE GLY PHE LEU THR VAL SEQRES 13 B 314 THR ASN LEU GLY VAL GLU ASN MET ASN HIS TYR LYS LYS SEQRES 14 B 314 THR THR LEU GLU ILE HIS ASN THR GLU GLU ARG GLN LYS SEQRES 15 B 314 ARG GLN VAL THR HIS PHE GLN PHE LEU SER TRP PRO ASP SEQRES 16 B 314 TYR GLY VAL PRO SER SER ALA ALA SER LEU ILE ASP PHE SEQRES 17 B 314 LEU ARG VAL VAL ARG ASN GLN GLN SER LEU ALA VAL SER SEQRES 18 B 314 ASN MET GLY ALA ARG SER LYS GLY GLN CYS PRO GLU PRO SEQRES 19 B 314 PRO ILE VAL VAL HIS CYS SER ALA GLY ILE GLY ARG THR SEQRES 20 B 314 GLY THR PHE CYS SER LEU ASP ILE CYS LEU ALA GLN LEU SEQRES 21 B 314 GLU GLU LEU GLY THR LEU ASN VAL PHE GLN THR VAL SER SEQRES 22 B 314 ARG MET ARG THR GLN ARG ALA PHE SER ILE GLN THR PRO SEQRES 23 B 314 GLU GLN TYR TYR PHE CYS TYR LYS ALA ILE LEU GLU PHE SEQRES 24 B 314 ALA GLU LYS GLU GLY MET VAL SER ALA HIS HIS HIS HIS SEQRES 25 B 314 HIS HIS HET A89 A 601 46 HETNAM A89 N-(4-BROMO-3-METHYLBENZOYL)-4-[DIFLUORO(PHOSPHONO) HETNAM 2 A89 METHYL]-L-PHENYLALANYL-N~5~-(3-IODOBENZOYL)-L- HETNAM 3 A89 ORNITHINAMIDE FORMUL 3 A89 C30 H31 BR F2 I N4 O7 P FORMUL 4 HOH *356(H2 O) HELIX 1 1 THR A 287 GLU A 313 1 27 HELIX 2 2 PHE A 319 SER A 324 1 6 HELIX 3 3 ASN A 327 ASN A 331 5 5 HELIX 4 4 LEU A 379 ASN A 381 5 3 HELIX 5 5 THR A 382 GLN A 393 1 12 HELIX 6 6 ALA A 477 MET A 498 1 22 HELIX 7 7 ILE A 519 GLY A 539 1 21 HELIX 8 8 ASN A 542 ARG A 551 1 10 HELIX 9 9 THR A 560 GLU A 578 1 19 HELIX 10 10 THR B 287 ARG B 312 1 26 HELIX 11 11 PHE B 319 SER B 324 1 6 HELIX 12 12 ASN B 327 ASN B 331 5 5 HELIX 13 13 LEU B 379 ASN B 381 5 3 HELIX 14 14 THR B 382 GLN B 393 1 12 HELIX 15 15 ALA B 477 SER B 496 1 20 HELIX 16 16 GLY B 520 GLY B 539 1 20 HELIX 17 17 ASN B 542 ARG B 551 1 10 HELIX 18 18 THR B 560 GLU B 578 1 19 SHEET 1 A 8 ALA A 360 GLY A 365 0 SHEET 2 A 8 GLN A 368 THR A 375 -1 O GLN A 368 N GLY A 365 SHEET 3 A 8 ILE A 511 HIS A 514 1 O VAL A 513 N ILE A 373 SHEET 4 A 8 VAL A 397 MET A 400 1 N VAL A 399 O VAL A 512 SHEET 5 A 8 GLN A 456 PHE A 465 1 O PHE A 463 N MET A 400 SHEET 6 A 8 TYR A 442 ASN A 451 -1 N THR A 445 O HIS A 462 SHEET 7 A 8 LEU A 429 ASN A 438 -1 N LEU A 434 O THR A 446 SHEET 8 A 8 ARG A 423 PHE A 426 -1 N PHE A 426 O LEU A 429 SHEET 1 B 2 GLU A 405 GLU A 406 0 SHEET 2 B 2 ARG A 409 ARG A 410 -1 O ARG A 409 N GLU A 406 SHEET 1 C 8 ALA B 360 GLY B 365 0 SHEET 2 C 8 GLN B 368 THR B 375 -1 O GLN B 368 N GLY B 365 SHEET 3 C 8 ILE B 511 HIS B 514 1 O ILE B 511 N ALA B 371 SHEET 4 C 8 VAL B 397 MET B 400 1 N VAL B 399 O VAL B 512 SHEET 5 C 8 GLN B 456 PHE B 465 1 O PHE B 463 N ILE B 398 SHEET 6 C 8 TYR B 442 ASN B 451 -1 N THR B 445 O HIS B 462 SHEET 7 C 8 LEU B 429 ASN B 438 -1 N GLU B 437 O LYS B 444 SHEET 8 C 8 ARG B 423 PHE B 426 -1 N PHE B 426 O LEU B 429 SHEET 1 D 2 GLU B 405 GLU B 406 0 SHEET 2 D 2 ARG B 409 ARG B 410 -1 O ARG B 409 N GLU B 406 CISPEP 1 GLY A 282 PRO A 283 0 0.05 CISPEP 2 GLY B 282 PRO B 283 0 -0.11 SITE 1 AC1 13 ARG A 311 TYR A 333 ASP A 335 CYS A 515 SITE 2 AC1 13 SER A 516 ALA A 517 GLY A 518 ILE A 519 SITE 3 AC1 13 GLY A 520 ARG A 521 PHE A 556 GLN A 559 SITE 4 AC1 13 HOH A 766 CRYST1 40.260 57.170 66.422 77.55 78.23 79.97 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024839 -0.004393 -0.004433 0.00000 SCALE2 0.000000 0.017763 -0.003377 0.00000 SCALE3 0.000000 0.000000 0.015654 0.00000